Evidence map›Paper›PMID 34520635›Full record

SynthesisBrain and behavior2021

A meta-analysis of comparisons of various surgical treatments for moyamoya diseases.

Kai Lin, Shaohua Sui, Jing Zhao, Liyong Zhang, Kun Chen

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Brain and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kai LinDepartment of Neurosurgery, Liaocheng People's Hospital, Liaocheng, P.R. China.
Shaohua SuiDepartment of Emergency, Liaocheng People's Hospital, Liaocheng, P.R. China.
Jing ZhaoDepartment of Pediatrics, Liaocheng People's Hospital, Liaocheng, P.R. China.
Liyong ZhangDepartment of Neurosurgery, Liaocheng People's Hospital, Liaocheng, P.R. China.
Kun ChenDepartment of Neurology, Liaocheng People's Hospital, Liaocheng, P.R. China.ORCID 0000-0002-4685-586X
Liaocheng People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIschemia is one of the most familiar complications in the different procedures for moyamoya disease (MMD), but the optimal surgical approaches for MMD remain unknown. We aimed to evaluate the efficiency of various surgical treatments.

methodsA literature search word was performed through four databases such as Cochrane Library, Web of Science, PubMed, and EMBASE for the literature published until May 2021. The I

resultsThere are a total of 18 studies including three surgical treatments such as including indirect, direct, and combined bypass in this study. The result revealed that indirect bypass was related to a higher incidence of recurrence stroke compared to the direct and combined bypass treatment (p = .001). Furthermore, the cases undergoing direct bypass were associated with a better angiographic change than the indirect bypass (OR = 3.254, p = .013).

conclusionThis meta-analysis demonstrated a positive effect of using the direct and combined bypass to treat MMD compared to indirect bypass due to their lower rates of recurrence stroke.

Indexed as

Cerebral RevascularizationMoyamoya DiseaseStrokeCerebral InfarctionDatabases, FactualHumansTreatment Outcomecombined bypassdirect bypassindirect bypassmoyamoya disease

Identifiers

PMID34520635
PMCPMC8553333
OpenAlexW3199956595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.